Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Sparing Analgesia Continuous Intraoperative Infusion of Dexmedetomidine Versus Lidocaine for Laparoscopic Cholecystectomy
NCT05788393Phase 4Completed
- Sponsor
- Assiut University
- Start
- Apr 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in pain comparing Dexmedetomidine group with Lidocaine group (2 arms). Primary endpoint: Maximum Numeric Pain Rating Scale at 6 hours. Started Apr 2024; status: completed.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05788393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05788393.